Stoke Therapeutics, Inc. (STOK)
28.70
-0.58
(-1.98%)
USD |
NASDAQ |
Jan 16, 16:00
28.95
+0.25
(+0.87%)
After-Hours: 20:00
Stoke Therapeutics Shareholders Equity (Annual): 229.02M for Dec. 31, 2024
Shareholders Equity (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Annual) Benchmarks
| Biogen, Inc. | 16.72B |
| Insmed, Inc. | 285.38M |
| Aldeyra Therapeutics, Inc. | 71.00M |
| Mirum Pharmaceuticals, Inc. | 225.64M |
| Moderna, Inc. | 10.90B |